1.SARS-CoV-2 Omicron variant: Immune escape and vaccine development

Ao, DY, Lan, TX, He,     More...

Ao, DY, Lan, TX, He, XM, Liu, J, Chen, L, Baptista-Hon, DT, Zhang, K, Wei, XW     Less

MEDCOMM[2688-2663], Published 2022, Volume 3, Issue 1,

收錄情况： WOS SCOPUS

WOS核心合集引用: 62  2022影響因子:  9.9  发表年影響因子:  9.9 

2.Homologous or heterogenous vaccination boosters enhance neutralizing activities against SARS-CoV-2 Omicron BA.1 variant

Zhou, ZC, Du, P, Li,     More...

Zhou, ZC, Du, P, Li, N, Xiong, XX, Tang, SJ, Dai, QN, Wang, TR, Yu, MX, Man, M, Lam, K, Baptista-Hon, DT, Tai, WH, Monteiro, O, Ng, WS, Lee, UM, Liu, ZH, Zhang, K, Li, G     Less

MEDCOMM[2688-2663], Published 2022, Volume 3, Issue 2,

收錄情况： WOS SCOPUS

WOS核心合集引用: 2  2022影響因子:  9.9  发表年影響因子:  9.9 

3.The challenges of COVID-19 Delta variant: Prevention and vaccine development

He, XM, He, C, Hong,     More...

He, XM, He, C, Hong, WQ, Zhang, K, Wei, XW     Less

MEDCOMM[2688-2663], Published 2021, Volume 2, Issue 4, Pages 846-854

收錄情况： WOS SCOPUS

WOS核心合集引用: 38  2022影響因子:  9.9